Evidence map›Paper›PMID 37703278›Full record

ArticlePLoS pathogens2023

Adenovirus protein VII binds the A-box of HMGB1 to repress interferon responses.

Edward A Arnold, Robin J Kaai, Katie Leung, Mia R Brinkley, Laurel E Kelnhofer-Millevolte, Monica S Guo, Daphne C Avgousti

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Edward A ArnoldDepartment of Microbiology, University of Washington, Seattle, Washington, United States of America.
Robin J KaaiMolecular & Cellular Biology, Graduate Program, University of Washington, Seattle, Washington, United States of America.
Katie LeungDepartment of Microbiology, University of Washington, Seattle, Washington, United States of America.
Mia R BrinkleyHuman Biology Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Laurel E Kelnhofer-MillevolteMedical Scientist Training Program, University of Washington, Seattle, Washington, United States of America.
Monica S GuoDepartment of Microbiology, University of Washington, Seattle, Washington, United States of America.
Daphne C AvgoustiDepartment of Microbiology, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0002-1700-3959
University of Washington · USFred Hutch Cancer Center · US

Funding

Investigating chromatin mechanisms using viral systemsR35GM133441 · NIGMS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Daphne Christina Avgousti · 2019 to 2026
$3.8M
Viral Pathogenesis Training ProgramT32AI083203 · NIAID · UNIVERSITY OF WASHINGTON · PI BLOOM, JESSE D, LAGUNOFF, MICHAEL · 2009 to 2023
$2.7M
Control of topoisomerase activity during DNA replication by bacterial chromosome structuring proteinsR00GM134153 · NIGMS · UNIVERSITY OF WASHINGTON · PI GUO, MONICA S. · 2021 to 2023
$747k
NIAID NIH HHS T32 AI083203NIGMS NIH HHS R00 GM134153NIGMS NIH HHS R35 GM133441
6 · The paper itself

Abstract

Viruses hijack host proteins to promote infection and dampen host defenses. Adenovirus encodes the multifunctional protein VII that serves both to compact viral genomes inside the virion and disrupt host chromatin. Protein VII binds the abundant nuclear protein high mobility group box 1 (HMGB1) and sequesters HMGB1 in chromatin. HMGB1 is an abundant host nuclear protein that can also be released from infected cells as an alarmin to amplify inflammatory responses. By sequestering HMGB1, protein VII prevents its release, thus inhibiting downstream inflammatory signaling. However, the consequences of this chromatin sequestration on host transcription are unknown. Here, we employ bacterial two-hybrid interaction assays and human cell culture to interrogate the mechanism of the protein VII-HMGB1 interaction. HMGB1 contains two DNA binding domains, the A- and B-boxes, that bend DNA to promote transcription factor binding while the C-terminal tail regulates this interaction. We demonstrate that protein VII interacts directly with the A-box of HMGB1, an interaction that is inhibited by the HMGB1 C-terminal tail. By cellular fractionation, we show that protein VII renders A-box containing constructs insoluble, thereby acting to prevent their release from cells. This sequestration is not dependent on HMGB1's ability to bind DNA but does require post-translational modifications on protein VII. Importantly, we demonstrate that protein VII inhibits expression of interferon β, in an HMGB1-dependent manner, but does not affect transcription of downstream interferon-stimulated genes. Together, our results demonstrate that protein VII specifically harnesses HMGB1 through its A-box domain to depress the innate immune response and promote infection.

Indexed as

HMGB1 ProteinInterferonsAdenoviridaeChromatinHumansNuclear ProteinsChromatinHMGB1 ProteinInterferonsNuclear Proteins

Identifiers

PMID37703278
PMCPMC10519595
OpenAlexW4386699642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.